217 related articles for article (PubMed ID: 21091985)
21. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
22. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
23. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.
Lee YH; Schwartz MD; Panganiban AT
Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906
[TBL] [Abstract][Full Text] [Related]
24. Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.
Halwani R; Khorchid A; Cen S; Kleiman L
J Virol; 2003 Apr; 77(7):3973-84. PubMed ID: 12634357
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
Liao WH; Wang CT
Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
Park J; Morrow CD
Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
[TBL] [Abstract][Full Text] [Related]
27. Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.
Pettit SC; Lindquist JN; Kaplan AH; Swanstrom R
Retrovirology; 2005 Nov; 2():66. PubMed ID: 16262906
[TBL] [Abstract][Full Text] [Related]
28. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.
Hill MK; Hooker CW; Harrich D; Crowe SM; Mak J
J Virol; 2001 Aug; 75(15):6835-40. PubMed ID: 11435562
[TBL] [Abstract][Full Text] [Related]
29. Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.
Sudo S; Haraguchi H; Hirai Y; Gatanaga H; Sakuragi J; Momose F; Morikawa Y
J Virol; 2013 Mar; 87(6):3348-60. PubMed ID: 23302874
[TBL] [Abstract][Full Text] [Related]
30. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.
Deora A; Spearman P; Ratner L
Virology; 2000 Apr; 269(2):305-12. PubMed ID: 10753709
[TBL] [Abstract][Full Text] [Related]
31. Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors.
Nishitsuji H; Yokoyama M; Sato H; Yamauchi S; Takaku H
FEBS Lett; 2011 Nov; 585(21):3372-7. PubMed ID: 22004763
[TBL] [Abstract][Full Text] [Related]
32. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.
Melamed D; Mark-Danieli M; Kenan-Eichler M; Kraus O; Castiel A; Laham N; Pupko T; Glaser F; Ben-Tal N; Bacharach E
J Virol; 2004 Sep; 78(18):9675-88. PubMed ID: 15331700
[TBL] [Abstract][Full Text] [Related]
33. [Interaction of gag polyprotein-precursors p55 and p48 with p160gag-pol during formation of virus-like particles of HIV-1 with recombinant strains of vaccinia virus].
Iordanskiĭ SN; Lideman LF; Chikova AK; Gibadulin RA
Vopr Virusol; 1997; 42(5):205-8. PubMed ID: 9424843
[TBL] [Abstract][Full Text] [Related]
34. Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1.
Costa LJ; Zheng YH; Sabotic J; Mak J; Fackler OT; Peterlin BM
J Virol; 2004 May; 78(10):5311-23. PubMed ID: 15137387
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.
Schwartz MD; Geraghty RJ; Panganiban AT
Virology; 1996 Oct; 224(1):302-9. PubMed ID: 8862425
[TBL] [Abstract][Full Text] [Related]
36. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
Scarlata S; Ehrlich LS; Carter CA
J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 protease regulation: the role of the major homology region and adjacent C-terminal capsid sequences.
Gatlin J; Arrigo SJ; Schmidt MG
J Biomed Sci; 1998; 5(4):305-8. PubMed ID: 9691224
[TBL] [Abstract][Full Text] [Related]
38. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.
Shehu-Xhilaga M; Kraeusslich HG; Pettit S; Swanstrom R; Lee JY; Marshall JA; Crowe SM; Mak J
J Virol; 2001 Oct; 75(19):9156-64. PubMed ID: 11533179
[TBL] [Abstract][Full Text] [Related]
39. Analysis of human immunodeficiency virus type 1 containing HERV-K protease.
Padow M; Lai L; Fisher RJ; Zhou YC; Wu X; Kappes JC; Towler EM
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1973-80. PubMed ID: 11153080
[TBL] [Abstract][Full Text] [Related]
40. Induced maturation of human immunodeficiency virus.
Mattei S; Anders M; Konvalinka J; Kräusslich HG; Briggs JA; Müller B
J Virol; 2014 Dec; 88(23):13722-31. PubMed ID: 25231305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
